Concepedia

Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial

Gemma D. Banham, Shaun Flint, Nicholas Torpey, Paul Lyons, Don N Shanahan, Adele Gibson, Christopher J.E. Watson, Ann-Marie O’Sullivan, Katie Foster, Rachel Jones,

The Lancet · 2018 · 91 citations · 33 references

DOIFull text

Open access

Concepts

References

33

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Sandra Navarra, Renato Guzmán, A Gallacher et al. · The Lancet · 2011 · 2K citations

, , +11

CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients

Paul A. Blair, Lina Yassin Noreña, Fabian Flores‐Borja et al. · Immunity · 2010 · 1.5K citations · Full text

, , +16

Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cells

Yohei Iwata, Takashi Matsushita, Mayuka Horikawa et al. · Blood · 2010 · 1.1K citations · Full text

, , +12

Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection

Duska Dragun, Dominik N. Müller, Jan Hinrich Bräsen et al. · New England Journal of Medicine · 2005 · 855 citations · Full text

, , +17

Molecular Heterogeneity in Acute Renal Allograft Rejection Identified by DNA Microarray Profiling

Minnie Sarwal, Mei‐Sze Chua, Neeraja Kambham et al. · New England Journal of Medicine · 2003 · 698 citations · Full text

, , +13